Core Insights - Significant mineralized sections have been intercepted in drill holes N2-25-003 and N2-25-008, located in the "A" and "RJ" zones [1] - The current drilling campaign at N2 marks the first since 2008, when Agnico conducted drilling in the "RJ" Zone, which previously identified high-grade intercepts of up to 51 g/t Au over 0.8 metres [1]

Core Viewpoint - Emerging Growth Research maintains a Buy-Extended rating for SBC Medical Group Holdings, Inc. with a 12-month price target of $9.00, indicating significant upside potential from its recent closing price of $3.57 on November 28, 2025 [1][2]. Financial Performance - Q3:25 revenue was $43.4 million, flat sequentially compared to Q2:25, but down 18% year-over-year due to changes in franchising fee structures. Management expects stabilization to continue through Q1:26 before returning to historical growth rates [6]. - Operating profit increased to $15.9 million in Q3:25, up from $13.8 million in Q3:24 and $14.6 million sequentially in Q2:25, reflecting effective cost management despite revenue pressures [6]. Growth and Expansion - The company added 34 new clinic locations year-over-year, reaching a total of 258 clinics, and annual customer visits grew to 6.5 million with a 72% repeat rate. Average revenue per visit increased to $298 in Q3:25 from $275 in Q1:25 [6]. - Management anticipates revenue will resume its historical compound annual growth rate (CAGR) of +10% to +15% starting in 2026, supported by domestic organic growth and plans to expand from 258 to 1,000 clinics over the next ten years, along with strategic mergers and acquisitions in Japan, Southeast Asia, and the United States [6]. Financial Position - SBC ended Q3:25 with a strong balance sheet, holding $127 million in cash, $83 million in accounts receivable, and $15 million in prepaid expenses, against only $21 million in long-term debt. Net cash represents approximately 40% of the company's current market capitalization [6]. - The firm's discounted cash flow (DCF) analysis indicates a fair value of $8.88 per share, rounded to $9.00, with a sensitivity range of $7.33 to $12.51 per share based on terminal growth and discount rate assumptions [5]. Market Position - SBC operates a franchise-based model that generates gross margins of 70%-75% with strong cash conversion, positioning it as an attractive consolidator in the fragmented global cosmetic treatment industry [4]. - The company became a Russell 3000 constituent in June 2025 and is exploring additional liquidity initiatives, including potential share buybacks and a dividend program [6].

Core Insights - Jaguar Mining Inc. has commenced drilling activities at the Chamé target, located three kilometers southeast of the Santa Isabel mine within the Paciência complex in Brazil's Iron Quadrangle [1] - The drilling began on November 21, 2025, with the first phase consisting of 12 drill holes totaling 3,040 meters [1]

Core Viewpoint - Target's stock is currently trading at a low price, with a price-to-earnings ratio of less than 11, raising questions about whether it represents a bargain or a value trap [1] Company Performance - Target has faced significant challenges, particularly as its core customers reduce discretionary spending due to high inflation [2] - Revenue declined by 1.5% in the third quarter of fiscal 2025, with comparable sales down 2.7%, leading to a decrease in earnings per share from $1.85 to $1.51 [3] Digital Sales - Despite overall sales struggles, digital sales have shown resilience, with digital comparable sales increasing by 2.4%, driven by a 35% rise in same-day options from Target's membership program [4] Competitive Landscape - Target's main competitors, Walmart and Costco, have performed better, with Walmart's comparable sales up 4.5% and Costco's up 5.7% in their most recent quarters [5] - Off-price retailer TJX Companies also reported a 5% year-over-year sales increase, highlighting Target's competitive challenges [5] Stock Performance - Target's stock has lost half its value over the past five years, erasing all pandemic gains, while the S&P 500 has risen significantly [6] - The company is undergoing a CEO transition, with Michael Fiddelke set to take over in January, although economic headwinds remain a concern [6] Key Financial Metrics - Current market capitalization is $41 billion, with a current stock price of $90.62 and a dividend yield of 5% [7] - Target has a gross margin of 25.36% and has consistently raised its dividend for 54 years, making it a "Dividend King" [7] Investment Considerations - Dividend investors may find the current yield attractive, as Target is known for reliable dividend growth and payments [8] - There is potential for stock price recovery if economic conditions improve, but caution is advised regarding timing [9]

After a record-breaking Black Friday, shoppers are filling their carts for the king of the online shopping season. Cyber Monday expected to bring in over 14 billion dollars in sales this year when experts say you'll find the best deals on apparel and computers. And retailers are hoping to add a new spin to their sales events, leaning into artificial intelligence.In the weeks leading up to peak holiday spending, chat GBT maker OpenAI partnered with Walmart and Target. Let's say I'm a little bit overwhelmed a ...

Core Viewpoint - The article emphasizes the focus on non-consensus long-short investment ideas within the biotechnology sector, particularly targeting small to mid-cap companies in the US and EU markets, with an interest in clinical catalysts and new drug launches [1]. Group 1: Investment Focus - The company specializes in identifying investment opportunities in small to mid-cap biotechnology firms that are publicly traded [1]. - There is a particular emphasis on clinical catalysts and earnings related to new drug launches as key areas of interest for investment [1]. Group 2: Analyst's Position - The analyst holds a beneficial long position in the shares of PHVS, indicating a personal investment interest in this specific company [2]. - The article is authored by the analyst without external compensation, reflecting personal opinions rather than institutional views [2]. Group 3: Content Disclaimer - The content provided is for informational and educational purposes only and should not be interpreted as financial or investment advice [3][4]. - The article acknowledges the potential for errors and inaccuracies, emphasizing the importance of conducting due diligence before making investment decisions [3].

Core Viewpoint - The focus is on identifying undervalued stocks with a strong potential for high returns while managing risks effectively [1] Group 1 - The investment strategy emphasizes the importance of understanding the assets owned to limit risks and maximize upside potential [1] - Simplicity in investment ideas is highlighted as a key factor, with a preference for contrarian approaches [1]

Core Viewpoint - Royal Helium Ltd. has successfully exited the CCAA Proceedings through a reverse takeover transaction with Keranic Industrial Gas Inc., marking a significant restructuring and strategic partnership in the helium sector [1][2]. Transaction Summary - The transaction involved a three-cornered amalgamation, resulting in the formation of a new wholly-owned subsidiary of Royal and the removal of the Target Companies from CCAA Proceedings [2]. - Prior to the amalgamation, Royal completed an 8:1 consolidation of its common shares and amended its articles to create two classes of shares: Class A common voting shares and Class B preferred non-voting shares [3]. - All existing debentures, options, and warrants of Royal were terminated as part of the transaction [3]. - The liabilities of the Target Companies were transferred to a residual company, while the assets were acquired by Keranic [4]. Financing Details - Keranic raised funds through a brokered subscription receipt financing of 7,030,000 subscription receipts at $0.50 each and a non-brokered common share offering of 75,901,328 Class A shares at $0.02108 each [6]. - The proceeds from these offerings were utilized to satisfy the purchase price of the transaction [6]. Strategic Investor - An affiliate of AirLife Gases Private Limited invested $2,000,000 in the Subscription Receipt Offering and $930,000 in the Share Offering, acquiring a significant stake of approximately 52.9% in Royal's Class A Shares post-transaction [9]. - The Strategic Investor is a well-established supplier of helium and specialty gases, with a strong presence in high-growth sectors such as healthcare and aerospace [10][12]. - The Strategic Investor has secured rights to nominate directors to Royal's board and has been granted corporate naming rights, subject to approval [13]. Asset Overview - The transaction encompasses Royal's extensive helium land position of approximately 600,000 acres across Saskatchewan and Alberta, with multiple helium discoveries [15]. - The Steveville plant facility, capable of processing 15,000 Mcf/day of raw gas, is expected to restart production within 12 weeks, with full capacity anticipated within 10 months [15]. Trading Update - Royal plans to apply for the listing of its Class A Shares on the TSX Venture Exchange, pending approval [16]. Advisory Information - Research Capital Corporation acted as the financial advisor for the transaction, with legal counsel provided by McDougall Gauley LLP [17].

NASDAQ on pace to snap a seven-month winning streak as tech drags. Joining me now, markets and data editor Jared Blickery, as well as Michelle Schneider, market gauge. com chief strategist.Jared, I want to start with you. Give us a look at the month here because we saw a lot of damage within tech and that looks like it's going to drag the NASDAQ lower on the month. >> You bet.And let's start with the uh Wi-Fi Interactive. And I'm going to pull up the month to date and this is going to be as of the close Wed ...

Group 1 - Americans spent $10 billion online on Black Friday 2025, indicating a strong trend for this year as well [1] - Amazon's quarterly revenue in North America was $106 billion last quarter, with Black Friday revenue expected to be between $2 billion to $3 billion [3] - Amazon Prime members spend approximately three times more than non-Prime shoppers, providing Amazon with a competitive advantage [4] Group 2 - Major retailers like Walmart and Target hold a significant market share, but Amazon's dominance continues to impact smaller retailers negatively [3][6] - Amazon's business model includes selling items from thousands of retailers, allowing it to earn revenue from each sale [3]